NYXH Nyxoah SA

$1.54▲ +2.67% Healthcare Other
After hours $1.49▼ -3.25% Sep 11, 7:49 PM ET
Volume 179.2K Avg Volume (10D) 978.9K
Key Metrics & Fundamentals
Market Cap
$156.83M
P/E Ratio
–
Div Yield
–%
52W Range
1.26 - 6.88
% vs 50 MA
-1.31%
% vs 200 MA
-50.66%
RSI-14
47.6
MACD Histogram
-0.0100
Beta (1Y vs SPY)
2.36
Free Cash Flow
-$17.86M
Gross Rev
$7.68M
Gross Profit
$4.58M
EBITDA
-$18.65M
COGS
$3.09M
Operating Exp
$25.13M
Operating Income
-$20.55M
EBIT
-$20.55M
Pretax Income
-$32.49M
Net Income
-$32.96M
EPS (Diluted)
-0.58
Price & Volume History
Loading chart…
Recent News
Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption?
Insider Monkey · Sep 10, 2026 9:18 PM
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial
Zacks · Sep 8, 2026 3:17 PM
Nyxoah Implants First Patient in Sleep Apnea Device Study
MT Newswires · Sep 8, 2026 8:51 AM
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
GlobeNewswire · Sep 7, 2026 8:05 PM
Nyxoah Shares Jump After Genio Meets Primary Endpoints in CCC Patient Study
MT Newswires · Sep 2, 2026 9:48 PM
Nyxoah Announces ACCCESS U.S. Pivotal Study Meets Primary Safety and Efficacy Endpoints in Complete Concentric Collapse Patients
GlobeNewswire · Sep 2, 2026 8:05 PM
Dr. Andrew Patel and Oath Surgical Bring Sleep Apnea Implant to Oregon in a First for Pacific Northwest Outpatient Surgery
Business Wire · Aug 26, 2026 3:00 PM
Information on the total number of voting rights and shares
GlobeNewswire · Aug 25, 2026 8:30 PM
Oppenheimer Adjusts Price Target on Nyxoah to $4 From $13, Maintains Outperform Rating
MT Newswires · Aug 6, 2026 1:49 PM
Nyxoah SA (NYXH) (Q2 2026) Earnings Call Highlights: US Revenue Surges 22% Sequentially, $110M ...
GuruFocus.com · Aug 6, 2026 5:07 AM
Financial Overview - Income Statement Quarterly

See NYXH's money flow as a full page

Social Sentiment
Avg +0.77 · 3 posts
NYXH - Nyxoah - FDA approval expected imminently
r/stocks · Aug 1, 2025
The anticipation of FDA approval is a strong bullish signal for the stock.
positive +0.70
NewsDiscussionDD2 Hidden Gems to Watch: Nyxoah & Biotalys
r/investing · Jan 17, 2025
The post highlights positive aspects such as innovative technology, market potential, and regulatory progress, indicating strong bullish sentiment.
positive +0.80
NewsDiscussionDD2 Hidden Gems to Watch: Nyxoah & Biotalys
r/StockMarket · Jan 17, 2025
The post expresses enthusiasm about Nyxoah's technology, regulatory progress, and partnerships.
positive +0.80
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙